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Michael P MacManus*, David Ball and Rodney J HicksAbstract
Dang and colleagues recently reported in the journal that tumor response to definitive chemoradiation, as assessed
using the RECIST criteria, and the risk of radiation pneumonitis were positively correlated in patients with non-small
cell lung cancer (NSCLC). We had previously reported similar findings in a study that used positron tomography
both to measure tumor response and to assess normal tissue toxicity in patients treated with chemoradiation for
NSCLC. Taken together these reports suggest that radiosensitivity of normal tissues and tumors may be strongly
linked in a proportion of patients with lung cancer.
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We read the recent article published in the journal by
Dang and colleagues with interest [1]. These authors re-
ported that tumor response to definitive chemoradiation,
as assessed using the Response Evaluation Criteria In Solid
Tumors (RECIST) criteria, and the risk of radiation pneu-
monitis were positively correlated in patients with non-
small cell lung cancer (NSCLC). This is not the first time
that such an association between tumor response and
radiation-induced pulmonary toxicity has been reported
in patients with NSCLC. In 2004, our group published the
results of a study that investigated the relationship be-
tween positron emission tomography (PET)-detected in-
flammatory changes in irradiated normal tissues and
clinical response at tumor sites in 73 patients treated with
radical radiotherapy or chemoradiotherapy for NSCLC
[2]. Radiation-induced inflammatory change was scored
for normal tissues within the radiation treatment volume
using a 0–3 grading scale. Metabolic tumor response was
assessed using standardized visual metabolic response
criteria. Increased fluorodeoxyglucose (FDG) uptake in
normal tissues (radiotoxicity) was associated with a greater
likelihood of complete or partial tumor response as* Correspondence: michael.macmanus@petermac.org
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article, unless otherwise stated.assessed by both PET (p =0.0044) and computed tomog-
raphy (p = 0.029). In a subsequent publication in 2011 we
reported that PET-detected radiotoxicity and radiation
pneumonitis were strongly associated [3]. FDG uptake in
pulmonary tissues therefore appeared to reflect the in-
flammatory changes induced by radiation pneumonitis.
Taken together, our results and the results reported by
Dang and colleagues suggest that the intrinsic radiosensi-
tivity of thoracic normal tissues and tumor responsiveness
to chemoradiation may be related in at least a proportion
of patients with NSCLC. These observations could poten-
tially have useful implications for patient management. If
the molecular basis of this phenomenon could be under-
stood, it may be possible in future to estimate the likely ra-
diosensitivity of both the tumor and the normal tissues of
individual patients with NSCLC and use this information
to better individualize therapy.
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